- Home
- CLDI vs MIGI Comparison
CLDI vs MIGI Comparison
Compare CLDI & MIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CLDI | MIGI |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 4.8M |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | CLDI | MIGI |
|---|---|---|
| Price | $0.32 | $2.52 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 269.0K | 45.0K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $43,571,720.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.28 |
| 52 Week High | $7.32 | $15.80 |
Technical Indicators
Market Signals| Indicator | CLDI | MIGI |
|---|---|---|
| Relative Strength Index (RSI) | 18.93 | 32.37 |
| Support Level | $0.22 | $0.36 |
| Resistance Level | $0.90 | $3.50 |
| Average True Range (ATR) | 0.05 | 0.24 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 0.53 | 5.10 |
Price Performance
Historical ComparisonAbout CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About MIGI Mawson Infrastructure Group Inc.
Mawson Infrastructure Group Inc is a digital infrastructure provider with diversified operations across Cryptocurrency Mining and Digital Asset Management. Its mission is to build a bridge between the rapidly emerging digital asset industry and traditional capital markets, with a focus on shareholder returns. The Company has three primary businesses: digital currency or Bitcoin self-mining, customer co-location and related services, and energy markets. It operates in a single segment surrounding its digital currency mining operation.